* CareMax Inc CMAX.OQ CMAX.O is expected to report
results on November 15.
* The Miami, Florida-based company is expected to report revenue
of $108.288 million, according to the mean estimate from 4
analysts, based on Refinitiv data.
* Refinitiv's mean analyst estimate for CareMax Inc is for a
loss of 8 cents per share.
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 4 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in the
last three months.
* Wall Street's median 12-month price target for CareMax Inc is
$14, about 39.5% above its last closing price of $8.47.
* Previous quarterly performance (using preferred earnings
measure in US dollars).
QUARTER STARMINESM REFINITIV ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT IBES MET, SE %
E® ESTIMATE MISSED
Jun. 30 2021 -0.04 -0.04 -0.26 Missed -550
2021
This summary was machine generated November 12 at 16:28 GMT.
All figures in US dollars unless otherwise stated